David Shimizu Selected Research

David Shimizu Research Topics

4	Neoplasms (Cancer) 01/2016 - 12/2004
2	Adenocarcinoma 08/2020 - 09/2016
2	Neoplasm Metastasis (Metastasis) 08/2017 - 01/2016
2	Endometrial Neoplasms (Endometrial Cancer) 01/2017 - 12/2004
2	Carcinoma (Carcinomatosis) 09/2016 - 01/2016
1	Lung Diseases (Lung Disease) 01/2020
1	Pneumothorax 01/2020
1	Tuberous Sclerosis (Bourneville's Disease) 01/2020
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2016
1	Wilms Tumor (Wilm's Tumor) 09/2016
1	Ductal Carcinoma 01/2014
1	Malignant Mesothelioma 05/2011
1	Aneuploidy (Aneuploid) 12/2004

1	lipoarabinomannan (LAM)IBA 01/2020
1	Monoclonal AntibodiesIBA 09/2016
1	Calbindin 2IBA 09/2016
1	Thyroid Nuclear Factor 1IBA 09/2016
1	CAM 5.2 antigenIBA 09/2016
1	Proteins (Proteins, Gene)FDA Link 09/2016
1	Keratin-5 (Keratin 5)IBA 09/2016
1	Coloring Agents (Dyes)IBA 09/2016
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2016
1	IntegrinsIBA 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014
1	Ribonucleases (Ribonuclease)IBA 05/2011
1	LuciferasesIBA 05/2011
1	ranpirnase (Pannon)IBA 05/2011
1	DNA (Deoxyribonucleic Acid)IBA 12/2004